EUVIMEDEUVIMED entdecken
Crossref

From the ground up: Launching GENETECA ™ ( GENetic education and TEsting for CAncer ) a point‐of‐care cancer genetics service at an academic medical center

Daniella Kamara iD, Mariana Niell Swiller, Sarah Bedford, Wendy Conlon, Ramil T Badana, Aletta Deranteriassian, Mehrnaz Siavoshi, Lorna Kwan, Jenny Lester, Timothy Donahue, Beth Y Karlan iD

Journal of Genetic Counseling · 2025-12 · 34 (6)

DOI: 10.1002/jgc4.70143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Genetic Counseling, online erschienen am 28.11.2025. Verfasst von Daniella Kamara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Point-of-Care Testing, Genetic Testing, Genetic Counseling. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2020, the UCLA Cancer Genetics service launched a point‐of‐care pilot program called GENETECA™ (GENetic Education and TEsting for CAncer) in the Pancreatic Cancer Integrated Practice Unit (PancIPU) to comply with national guidelines recommending universal germline genetic testing (gGT). We present a guide for the implementation of similar models at other institutions along with the uptake and outcomes of GENETECA. Patients with pancreatic ductal adenocarcinoma (PDAC) obtaining care at UCLA Health between August 12, 2020 and January 1, 2023 were identified through electronic medical record review. Abstracted data included patient demographics and GENETECA endpoints (gGT, opted for traditional genetic counseling visit, declined, or loss to follow up). Data were analyzed using Chi‐squared testing for categorical variables and Wilcoxon rank‐sum tests for non‐parametric data. In 2019, prior to the implementation of GENETECA, only 9% (18/194) of patients with PDAC seen at PancIPU had pre‐test counseling and gGT by cancer genetic counselors. After the implementation of GENETECA, 94% (222 out of 237) of PDAC patients were offered gGT. Approximately 80% of patients with PDAC who were offered GENETECA proceeded with testing, independent of patient age. Non‐English speakers were no less likely to complete GENETECA than English‐speaking patients, and no significant difference in completion was observed across races. Implementing this point‐of‐care, high‐throughput approach significantly improved compliance with national guidelines and proved to be a cost‐effective service delivery model. Its success has allowed us to procure additional financial and health system support to expand cancer genetic services across many other tumor‐site specialty clinics. Our described implementation may be used as a framework for other institutions to implement similar models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPoint-of-Care TestingGenetic TestingGenetic CounselingOncology Service, HospitalHumansPilot ProjectsCarcinoma, Pancreatic DuctalAdenocarcinomaEarly Detection of CancerMaleFemaleMiddle AgedAgedAged, 80 and overAcademic Medical CentersProgram EvaluationHealth Plan Implementation

Stichwörter der Autor:innen

cancer geneticsgenetics servicesscalableservice delivery models

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • UCLA Health-Cancer Services, Los Angeles, California, USA.
  • Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • UCLA-Jonsson Comprehensive Cancer Center, Los Angeles, California, USA.

ORCID-Profile: Daniella Kamara, Beth Y Karlan

Zitieren

APA

Kamara, D., Swiller, M. N., Bedford, S., Conlon, W., Badana, R. T., Deranteriassian, A., Siavoshi, M., Kwan, L., Lester, J., Donahue, T., & Karlan, B. Y. (2025). From the ground up: Launching GENETECA ™ ( GENetic education and TEsting for CAncer ) a point‐of‐care cancer genetics service at an academic medical center. Journal of Genetic Counseling, 34(6). https://doi.org/10.1002/jgc4.70143

Vancouver

Kamara D, Swiller MN, Bedford S, Conlon W, Badana RT, Deranteriassian A, et al. From the ground up: Launching GENETECA ™ ( GENetic education and TEsting for CAncer ) a point‐of‐care cancer genetics service at an academic medical center. Journal of Genetic Counseling. 2025;34(6). doi:10.1002/jgc4.70143

BibTeX
@article{Kamara2025,
  author = {Kamara, Daniella and Swiller, Mariana Niell and Bedford, Sarah and Conlon, Wendy and Badana, Ramil T and Deranteriassian, Aletta and Siavoshi, Mehrnaz and Kwan, Lorna and Lester, Jenny and Donahue, Timothy and Karlan, Beth Y},
  title = {From the ground up: Launching GENETECA ™ ( GENetic education and TEsting for CAncer ) a point‐of‐care cancer genetics service at an academic medical center},
  journal = {Journal of Genetic Counseling},
  year = {2025},
  volume = {34},
  number = {6},
  doi = {10.1002/jgc4.70143}
}
Kostenlos starten →